Subscribe to our mailing list to receive research, advocacy and other updates from MS Australia
Categories
date range
MS Australia News
MS News
Unifying MS – research updates from MSToronto2026
28 October 2026
The latest in MS diagnosis, therapies, clinical trials, care and science was presented at the world’s largest conference on MS and related disorders in Toronto, Canada, in October 2026.
Hearing lived experience voices on mental health and MS
8 October 2026
This World Mental Health Day 2026 (10 October), members of our Lived Experience Expert Panel (LEEP) share their experiences of managing mental health while living with MS, including seeking professional support, staying active, connecting with others and adapting to changing circumstances.
LEEP member, Julie shares her experience of MS diagnosis and how she's learned to manage her health over the years.
"Having MS means I am constantly “assessing” my body and listening to how I feel. I try not to do too much and take rest breaks as needed."
More than 3 million people are now living with MS worldwide
29 September 2026
Latest estimates show that more than 3 million people are living with MS worldwide. The rise is likely influenced by earlier diagnosis, improved care and stronger data collection, highlighting the growing global impact of MS and the need for action.
CEO Rohan Greenland discusses encouraging early results from the OCTOPUS/PLATYPUS trials, the Global MS Prevention Initiative showcased at the UN General Assembly, and the need for an Australian action plan for neurological conditions.
Early results show world-first adaptive trial in action for progressive MS
17 September 2026
A potential treatment for progressive multiple sclerosis (MS) will continue in a world-first multi-arm, multi-stage adaptive trial after showing encouraging early signs, with recruitment set to expand across Australia.
Alpha lipoic acid shows promise in Stage 1 of Octopus trial in progressive MS
17 September 2026
Results from Stage 1 of the Octopus trial find one of the trial treatments, alpha lipoic acid, shows promise in progressive MS and will continue into trial Stage 2.
Women and MS: one of the disease’s biggest mysteries
9 September 2026
Why does MS affect women more often than men? How does female biology impact MS activity? Discover what recent research is revealing about risk, hormones, immunity and EBV.
